QuVa Pharma, Inc. is recalling 75,885 syringes of R.E.C.K. (ropivacaine HCl, epinephrine, clonidine HCl, and ketorolac tromethamine) in Sodium Chloride Solution (50 mL syringes). The recall was initiated because particulate matter was found in the solution. This compounded medication is an injection intended for periarticular use (around a joint) and is not for intravenous use.
The presence of particulate matter in an injectable drug can cause local inflammation, tissue damage, or small vessel blockages if the particles are injected into the body. While no injuries have been reported, the contamination poses a medium risk to patient safety.
QuVA Pharma, 1075 West Park One Drive, Suite 100, Sugar Land, TX 77478. THIS IS A COMPOUNDED DRUG.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.